Introduction: Hexavalent chromium [Cr (VI)] has been identified as a human carcinogen and environmental pollutant capable of affecting multiple systems in the human body. However, the specific mechanisms by which Cr (VI) affects the human nervous system remain unclear. Objective: Following confirmation of Cr (VI)\'s toxic effects on rat astrocytes, this study explores the metabolites and associated metabolic pathways of rat astrocytes under different doses of Cr (VI) exposure. Methods: Cell viability was assessed using CCK8 assays, intracellular reactive oxygen species (ROS) levels were measured using DCFH-DA fluorescent probes, intracellular 8-hydroxydeoxyguanosine (8-OHdG) content was determined by Elisa, mitochondrial membrane potential was observed using JC-1 probes, and key metabolites were identified through untargeted metabolomics analysis. Results: With increasing Cr (VI) doses, significant decreases in cell viability were observed in the 4, 8, and 16 mg/L dose groups (p < 0.05). Elevated levels of ROS and 8-OHdG, increased caspase-3 activity, and significant reductions in mitochondrial membrane potential were observed in the 2 and 4 mg/L dose groups (p < 0.05). Untargeted metabolomics analysis revealed Cr (VI)\'s impact on key metabolites such as sphingosine and methionine. Enrichment analysis of KEGG pathways highlighted the critical roles of sphingolipid metabolism and the methionine-cysteine cycle in the effects of Cr (VI) on rat astrocytes. Conclusion: Our study underscores the potential neuro-health risks associated with environmental and occupational exposure to Cr (VI) and provides new perspectives and directions for investigating neurotoxic mechanisms.

OBJECTIVE: This study aimed to analyze the possible role of rDNA copy number variation in the association between hexavalent chromium [Cr (VI)] exposure and semen quality in semen donors and further confirm this association in mice.
METHODS: In this cross-sectional study, whole blood and semen samples were collected from 155 semen donors in the Zhejiang Human Sperm Bank from January 1st to April 31st, 2021. Adult C57BL/6 J male mice were treated with different doses of Cr (VI) (0, 10, or 15 mg/kg b.w./day). Semen quality, including semen volume, total spermatozoa count, sperm concentration, progressive motility, and total motility, were analyzed according to the WHO laboratory manual. Cr concentration was detected using inductively coupled plasma mass spectrometry. The rDNA copy number was measured using qPCR.
RESULTS: In semen donors, whole blood Cr concentration was negatively associated with semen concentration and total sperm counts. Semen 5 S and 45 S rDNA copy numbers were negatively associated with whole blood Cr concentration and whole blood 5.8 S rDNA copy number was negatively associated with semen Cr concentration. In mice, Cr (VI) damaged testicular tissue, decreased semen quality, and caused rDNA copy number variation. Semen quality was related to the rDNA copy number in whole blood, testicular tissue, and semen samples in mice.
CONCLUSIONS: Cr (VI) was associated with decreased semen quality in semen donors and mice. Our findings suggest an in-depth analysis of the role of the rDNA copy number variation in the Cr (VI)-induced impairment of semen quality.

BACKGROUND: Hexavalent chromium (Cr(Ⅵ)) is classified as a group 1 human carcinogen and increases the risk of lung cancer. Non-coding RNAs (ncRNAs) have key regulatory roles in lung cancer, but less is known about their relation to Cr(Ⅵ) exposure.
OBJECTIVE: We aimed to 1) measure the expression of lung cancer-related circulating ncRNAs in exposed workers and controls; 2) assess associations between ncRNAs expression and Cr concentrations in red blood cells (RBC) and urine; and 3) evaluate correlations between the ncRNAs.
METHODS: The study included 111 Cr(VI) exposed workers and 72 controls recruited from the SafeChrom project. Cr concentrations were measured in RBC (biomarker of long-term exposure) and urine (biomarker of short-term exposure) samples. Long ncRNA (lncRNA) and microRNA (miRNA) were extracted from plasma followed by deoxyribonuclease treatment, complementary DNA synthesis, and quantitative real-time polymerase chain reaction using target-specific assays for three lncRNAs (H19, MALAT1, NORAD), and four miRNAs (miR-142-3p, miR-15b-5p, miR-3940-5p, miR-451a).
RESULTS: Expression levels of lncRNAs MALAT1 and NORAD, and all four miRNAs, were significantly lower in Cr(VI) exposed workers compared with controls, and correlated significantly with RBC-Cr concentrations (rS = -0.16 to -0.38). H19 was non-significantly increased in exposed workers but significantly correlated with miR-142-3p (rS = -0.33) and miR-15b-5p (rS = -0.30), and NORAD was significantly positively correlated with all four miRNAs (rS = 0.17 to 0.46). In multivariate regression models adjusting for confounders, expressions of lncRNAs MALAT1 and NORAD and all miRNAs were still significantly lower in the exposed group compared with controls, and the expression decreased with increasing RBC-Cr concentrations.
CONCLUSIONS: Cr(VI) exposure was inversely and in a dose-response manner associated with the expression of circulating non-coding RNA, which suggests ncRNAs as potential biomarkers for Cr(VI)-induced toxicity. Correlations between miRNAs and lncRNAs suggest that they participate in the same lncRNA-miRNA-messenger RNA regulatory axes, which may play important roles in Cr(VI) carcinogenesis.

OBJECTIVE: Hexavalent chromium (Cr(VI)) is classified as a human carcinogen. Occupational Cr(VI) exposure can occur during different work processes, but the current exposure to Cr(VI) at Swedish workplaces is unknown.
METHODS: This cross-sectional study (SafeChrom) recruited non-smoking men and women from 14 companies with potential Cr(VI) exposure (n = 113) and controls from 6 companies without Cr(VI) exposure (n = 72). Inhalable Cr(VI) was measured by personal air sampling (outside of respiratory protection) in exposed workers. Total Cr was measured in urine (pre- and post-shift, density-adjusted) and red blood cells (RBC) (reflecting Cr(VI)) in exposed workers and controls. The Bayesian tool Expostats was used to assess risk and evaluate occupational exposure limit (OEL) compliance.
RESULTS: The exposed workers performed processing of metal products, steel production, welding, plating, and various chemical processes. The geometric mean concentration of inhalable Cr(VI) in exposed workers was 0.15 μg/m3 (95% confidence interval: 0.11-0.21). Eight of the 113 exposed workers (7%) exceeded the Swedish OEL of 5 μg/m3, and the Bayesian analysis estimated the share of OEL exceedances up to 19.6% for stainless steel welders. Median post-shift urinary (0.60 μg/L, 5th-95th percentile 0.10-3.20) and RBC concentrations (0.73 μg/L, 0.51-2.33) of Cr were significantly higher in the exposed group compared with the controls (urinary 0.10 μg/L, 0.06-0.56 and RBC 0.53 μg/L, 0.42-0.72). Inhalable Cr(VI) correlated with urinary Cr (rS = 0.64) and RBC-Cr (rS = 0.53). Workers within steel production showed the highest concentrations of inhalable, urinary and RBC Cr. Workers with inferred non-acceptable local exhaustion ventilation showed significantly higher inhalable Cr(VI), urinary and RBC Cr concentrations compared with those with inferred acceptable ventilation. Furthermore, workers with inferred correct use of respiratory protection were exposed to significantly higher concentrations of Cr(VI) in air and had higher levels of Cr in urine and RBC than those assessed with incorrect or no use. Based on the Swedish job-exposure-matrix, approximately 17 900 workers were estimated to be occupationally exposed to Cr(VI) today.
CONCLUSIONS: Our study demonstrates that some workers in Sweden are exposed to high levels of the non-threshold carcinogen Cr(VI). Employers and workers seem aware of Cr(VI) exposure, but more efficient exposure control strategies are required. National strategies aligned with the European strategies are needed in order to eliminate this cause of occupational cancer.

The present study discusses the effect of the addition of nano-sized arc stabilizing materials on fume emissions and its solubility characteristics. Micro and nano-sized sodium/potassium titanates were added to the SMAW electrode flux as a substitute for the conventional sodium and potassium silicate compounds. The total and soluble metal concentration of fumes from the newly developed electrodes were estimated and compared with that of commercially available electrodes. The estimation of fume formation rate and breathing zone concentration of fumes followed the ISO 15011-1 and ISO 10882-1 standard. An average 50% reduction in the soluble fraction of fumes was observed from the electrodes containing micro-sized potassium-titanate compounds, and the reduction was further improved by 60% when nano-sodium titanate was added to the flux. Whereas, the reduction in soluble metal concentration for potassium titanate coated electrodes were 45% and 55%, in that order, for their micro and nano-structured forms. The soluble fraction of hexavalent chromium from the electrodes containing 100% nano sodium/potassium titanates was reduced up to 50% in each impactor stage. The inclusion of nano-sized sodium titanate in the flux resulted in a reduction in fume formation rate up to 55% and breathing zone concentration of fumes by 58% compared to the conventional sodium silicate coated electrodes. The electrode assaying 100% nano-potassium titanate showed a reduction of 59% in fume formation rate and 61% in breathing zone concentration compared to that of conventional potassium silicate-coated electrodes.

Zero-valent iron (ZVI) and modified ZVI have been investigated extensively for groundwater remediation. However, ZVI based powder was difficult to be applied directly as permeable reactive barrier (PRB) materials due to their low water permeability and usage rate. In this study, sulfide iron-copper bimetal was prepared by ball milling, which is environment-friendly without second contamination. The optimal preparation parameters of sulfide iron-copper bimetal for Cr(VI) removal were determined (Cu/Fe ratio (w/w), 0.018; FeS/Fe ratio (w/w), 0.1213; ball milling speed, 450 rpm; ball milling time, 5 h). A composite permeable material was prepared by sintering a mixture of sulfide iron-copper bimetal, sludge, and kaolin. The parameters for composite permeable material preparation including sludge content and particle size, and sintering time were optimized, which were 60%, 60-75 mesh, and 4 h, respectively. The optimal composite permeable material was characterized by SEM-EDS, XRD, and FTIR. The results demonstrated preparation parameters can affect the hydraulic conductivity and hardness of composite permeable material. High sludge content, small particles size, and moderate sintering time resulted in high permeability of composite permeable material and were beneficial for Cr(VI) removal. The dominant Cr(VI) removal mechanism was reduction, and the reaction followed pseudo-first order kinetics. Conversely, low sludge content and large particle size, and long sintering time lead to low permeability of composite permeable material. Chromate removal was mainly by chemisorption following pseudo-second order kinetics. The hydraulic conductivity and hardness of the optimal composite permeable material achieved 1.732 cm/s and 50, respectively. The results of column experiments indicated that its Cr(VI) removal capacity was 0.54 mg/g, 0.39 mg/g and 0.29 mg/g at pH 5, 7 and 9, respectively. The ratio of Cr(VI) to Cr(III) on composite permeable material surface was similar under acidic and alkaline conditions. This study will provide an effective reactive material of PRB for field application.

Chromium (Cr) and its compounds are closely associated with individuals\' lives and extensively used in industry. Excessive exposure to hexavalent chromium (Cr(VI)) induces oxidative damage of various organs including the testes, posing a serious threat to male reproductive fitness. As an endogenous antioxidant, melatonin holds potent antioxidative and anti-inflammatory properties, becoming a potential candidate for treatment of a variety of diseases, including reproductive disorders. Here, by using a mouse model, we systematically assessed Cr(VI)-induced damage to male fertility as well as the preventive role of melatonin. We analyzed the histology and pathology of the testis and epididymis, the density, viability, and malformation of caudal epididymal sperm, the proliferative activity and apoptosis of various spermatogenic subtypes and Sertoli cells, as well as the fertility of mice at five timepoints within one cycle of spermatogenesis (Days 0, 14, 21, 28, and 35) post 14 days of Cr(VI) and/or melatonin intraperitoneal injection. We identified that the testicular damage caused by Cr(VI) persisted to Day 21 after administration and then started to be alleviated, with clear alleviation on Day 35. Pretreatment with melatonin evidently reduced Cr(VI)-induced testicular damage and accelerated spermatogenic restoration, generating an almost normal phenotype on Day 35. Melatonin pretreatment also retained the sperm quality at all time points investigated. Moreover, melatonin to some extent preserved the fertility of Cr(VI)-treated mice without apparent side effects. The findings shed light on the future clinical application of melatonin as a therapeutic agent for environmental heavy metal toxicant-induced male subfertility or infertility.

In this study, CTS-GSH was prepared by grafting thiol (-SH) groups onto chitosan (CTS), which was characterized through Fourier Transform Infrared (FT-IR) spectra, Scanning Electron Microscopy (SEM) and Differential Thermal Analysis-Thermogravimetric Analysis (DTA-TG). The performance of CTS-GSH was evaluated by measuring Cr(VI) removal efficiency. The -SH group was successfully grafted onto CTS, forming a chemical composite, CTS-GSH, with a rough, porous and spatial network surface. All of the molecules tested in this study were efficient at removing Cr(VI) from the solution. The more CTS-GSH added, the more Cr(VI) removed. When a suitable dosage of CTS-GSH was added, Cr(VI) was almost completely removed. The acidic environment at pH 5-6 was beneficial for the removal of Cr(VI), and at pH 6, the maximum removal efficiency was achieved. Further experimentation showed that with 100.0 mg/L CTS-GSH for the disposal of 5.0 mg/L Cr(VI) solution, the removal rate of Cr(VI) reached 99.3% with a slow stirring time of 8.0 min and sedimentation time of 3 h; the presence of four common ions, including Mg2+, Ca2+, SO42- and CO32-, had an inhibitory effect on CTS-GSH\'s ability to remove Cr(VI) from the aqueous solution, and more CTS-GSH was needed to reduce this inhibiting action. Overall, CTS-GSH exhibited good results in Cr(VI) removal, and thus has good potential for the further treatment of heavy metal wastewater.

The degradation of phenylic contaminants (phenol, hydroquinone, nitrobenzene, p-nitrophenol) containing Cr(VI) has been investigated in a dielectric barrier discharge (DBD) system using a ZnCo2O4 composite catalyst. The ZnCo2O4 nanowires combined with multi-walled carbon nanotubes (MWNTs) on a sponge substrate in the discharge system can induce a decrease in the corona inception voltage and discharge becomes more stable resulting in an improvement in the energy utilization efficiency. With the synergistic degradation of phenylic species containing Cr(VI), the total elimination efficiency was further improved. The active substances (H2O2 and O3) were detected in the discharged solution, and some of them were consumed in the phenylic system. The effects of ·OH, O2·- and e- were also verified using free radical trapping experiments in which ·OH exhibited the main oxidation effect for the degradation of phenylic pollutants, and e-, H2O2 and H· affect the reduction of Cr(VI). The intermediate products were determined in order to analyze the degradation process of phenylic pollutants by the ZnCo2O4 composite catalyst in combination with the DBD system. The electron transfer process in the ZnCo2O4 composite catalyst during discharge was analyzed. Finally, the biotoxicity of the phenylic pollutants before and after degradation was compared.

In this study, a novel in situ iron-loaded activated carbon (AFPAC) was prepared by a FeSO4/K2FeO4 impregnation and oxidation combination two-step supported on activated carbon for enhanced removal of Cr(VI) from aqueous solutions. Cr(VI) removal efficiency greatly increased by AFPAC more than 70% than that of fresh activated carbon (AC), which is due to rich iron oxides formed in situ and the synergistic effect between iron oxides and activated carbon. Cr(VI) adsorption behaviors on AFPAC under different water quality parameters were investigated. The maximum monolayer adsorption capacities for Cr(VI) by AFPAC are as high as 26.24 mg/g, 28.65 mg/g, and 32.05 mg/g at 25 °C, 35 °C and 45 °C at pH 4, respectively. Density functional theory (DFT) results showed that the adsorption energy of K2Cr2O7 on the surface of FeOOH was - 2.52 eV, which was greater than that on the surface of bare AC, and more charge transfer occurred during the adsorption of K2Cr2O7 on the surface of FeOOH, greatly promoting the formation of Cr = O-Fe. Cr(VI) removal by AFPAC included electrostatic attraction, redox reaction, coordinate complexation, and co-precipitation. Cr(VI) adsorption process on AFPAC consisted of the three reaction steps: (1) AFPAC was fast protonation and Cr2O72- would electrostatically attract to the positively charged AFPAC surface. (2) Cr2O72- was reduced into Cr2O3 by the carbons bond to the oxygen functionalities on activated carbon and the redox reaction process of FeSO4 and K2FeO4. (3) The inner-sphere complexes were formed, and adsorbed on AFPAC by iron oxides and then co-precipitation.